BioInfra Co.,Ltd.

Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.

199730 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시
Website:: http://bioinfra.co.kr/?lang=en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Co., Ltd. is a global healthcare and biotechnology company focused on advancing human health through innovative solutions for disease prevention and treatment. The company's core activities are centered on two primary business segments: diagnostics development and contract research organization (CRO) services. Its flagship product is a proprietary multi-biomarker blood test, a screening technology designed for the early detection of risk for eight major types of cancer. The company's CRO division provides comprehensive support to the pharmaceutical industry, offering services that include Phase 1 clinical trials, bioequivalence testing, immunoassays, and pharmaceutical quality inspections.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioInfra Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Psych Capital Plc A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.	United Kingdom	PSY
Pure Biologics S.A. Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.	Poland	PUR
Puretech Health PLC A clinical-stage biotherapeutics company developing new medicines for devastating diseases.	United States of America	PRTC
PZ Cormay S.A. Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.	Poland	CRM
Quantum Genomics Biopharma developing cardiovascular treatments, now in judicial liquidation.	France	ALQGC
Quratis Inc. Develops infectious disease vaccines and offers biologics CDMO services for global health.	South Korea	348080
Recordati Industria Chimica e Farmaceutica Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.	Italy	REC
Rekah Pharmaceutical Prod Ltd. A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.	Israel	REKA
Replek AD Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.	North Macedonia	REPL
Respiratorius AB Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.	Sweden	RESP